EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Decoding the breast cancer microenvironment by spatial multi-omics: from architecture to clinical translation

Yi Xiao, Yuxin Ding, Kun Ji

Clinical and Translational Oncology · 2026

DOI: 10.1007/s12094-026-04398-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, 2026. Verfasst von Yi Xiao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, The First Hospital of Lanzhou University, Lanzhou, 730000, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 103 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spatial multi-omics technologies are fundamentally shifting breast cancer research from static molecular inventories toward high-resolution spatial atlases of the tumor microenvironment (TME). By integrating spatial transcriptomics, spatial proteomics, and emerging metabolomic approaches, researchers can now map tumor cell heterogeneity, stromal cell subtypes, immune cell topography, and tertiary lymphoid structures (TLSs) within their native tissue context. These spatial insights have enabled the construction of prognostic models based on tumor-immune interface distances, improved prediction of chemotherapy and immunotherapy responses, and facilitated the design of niche‑specific combination therapies targeting, for example, fibroblasts‑rich or immunosuppressive regions. Despite these advances, major challenges remain, including multi‑modal data integration, batch effects, high costs, and the lack of standardized protocols for clinical implementation. Overcoming these bottlenecks is essential to establish "spatial pathology" as a routine tool in precision oncology, ultimately guiding more effective, personalized treatment strategies for breast cancer patients. Importantly, it should be noted that the clinical readiness of spatial features varies substantially: assessment of TLS on routine H&E sections is near-implementation, while high-dimensional spatial transcriptomic and proteomic signatures still require standardized protocols, prospective validation, and cost reduction before entering routine diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentBreast NeoplasmsHumansFemaleMultiomicsProteomicsSpatial TranscriptomicsTranslational Research, BiomedicalMetabolomics

Stichwörter der Autor:innen

ImmuneSpatial sequencingTumor microenvironment

Autor:innen und Institutionen

  • Department of Breast Surgery, The First Hospital of Lanzhou University, Lanzhou, 730000, China.
  • First Clinical Medical College of Kunming Medical University, Kunming, China.
  • Department of Breast Surgery, The First Hospital of Lanzhou University, Lanzhou, 730000, China. jikun139@163.com.

Zitieren

APA

Xiao, Y., Ding, Y., & Ji, K. (2026). Decoding the breast cancer microenvironment by spatial multi-omics: from architecture to clinical translation. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-026-04398-2

Vancouver

Xiao Y, Ding Y, Ji K. Decoding the breast cancer microenvironment by spatial multi-omics: from architecture to clinical translation. Clinical and Translational Oncology. 2026. doi:10.1007/s12094-026-04398-2

BibTeX
@article{Xiao2026,
  author = {Xiao, Yi and Ding, Yuxin and Ji, Kun},
  title = {Decoding the breast cancer microenvironment by spatial multi-omics: from architecture to clinical translation},
  journal = {Clinical and Translational Oncology},
  year = {2026},
  doi = {10.1007/s12094-026-04398-2}
}
Kostenlos starten →